Pay in 4 interest-free payments of $5.30 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Not intended to diagnose, treat, cure, or prevent any medical condition
That means the same level of appetite suppression from a GLP-1 medication can produce different weight loss outcomes depending on a persons muscle mass and activity level
Compounders are limited to preparing the medication in multi-dose vials, which requires patients to use insulin syringes and perform their own dose calculations
Not for human or veterinary use 30 in stock Cagrilintide / Semaglutide Blend Current Batch: 11048-004 Test Date: Feb 9th, 2026 Purity: 99.771 Cagrilintide Net Content: 6.73 Semaglutide New Content: 6.03mg Cag/Sema(GLP -CS) Cap Color: Pink Product Description This blended formulation combines cagrilintide and Semaglutide, synthetic peptide analogs frequently referenced in metabolic and receptor pathway research
We recognize the importance of managing side effects, so your care plan may include medication to alleviate them
